Marvin Samson is Director at ANTARES PHARMA, INC. (ATRS). They have made 4 open-market trades across 1 company since 2014, most recently 2020-01-10.
CIK 0000901056
2 open-market purchases totalling $86K since 2014, against 2 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| ATRS | 51,751 | $289K |
Shares reported on the most recent Form 4, priced at the 2020-01-14 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| ATRS | SELL · 10b5-1 | 2020-01-10 | 2020-01-14 | $4.50 | $252 | -10.7% | -20.4% | -40.9% |
| ATRS | SELL | 2020-01-02 | 2020-01-06 | $4.60 | $686K | +4.2% | -9.9% | -46.7% |
| ATRS | SELL | 2019-12-23 | 2019-12-26 | $4.71 | $707K | -10.1% | -15.4% | -52.8% |
| ATRS | BUY | 2016-03-18 | 2016-03-21 | $0.72 | $36K | +10.9% | +8.3% | +25.6% |
| ATRS | BUY | 2014-08-11 | 2014-08-12 | $2.00 | $50K | -22.0% | -2.5% | -2.5% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.